About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 3NCT00141193

Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)

This study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial to compare the efficacy and safety of celecoxib 400mg QD versus placebo in reducing the occurrence of new ...

Lead sponsor: Pfizer•10 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Pfizer

Age

30 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•The subject has had a documented colonoscopy to the cecum performed by a study-related physician with adequate preparation resulting in diagnosis and clearance of an adenomatous polyp(s) within 4 months prior to randomization.
•The subject is willing to abstain from chronic use of all NSAIDs or COX-2 inhibitors excluding aspirin at cardioprotective doses for the duration of the study.

Exclusion Criteria

•The subject has a history of Familial Adenomatous Polyposis or Hereditary Non-Polyposis Colorectal Cancer.
•The subject has a history of inflammatory bowel disease.

Related studies

PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

NCT06133387 · Colorectal Lesion, Colorectal Adenoma, and more

New bioMarkers tO straTIfy cOlorectal caNcer Referrals

NCT07035691 · Colorectal Carcinoma, Polyp, and more

Early Diagnosis of Colorectal Cancer Based on a Non-invasive Metabolomics Profile

NCT06452745 · Colorectal Cancer, Colorectal Adenoma, and more

Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)

NCT05144152 · Colorectal Adenoma, Advanced Adenoma, and more

RECRUITINGPhase 2

Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA)

NCT06205862 · Fecal Microbiota Transplantation, Colorectal Adenoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 6, 2008Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment1,561

Start dateFeb 2001

Last updatedAug 6, 2008

Condition

Colorectal Adenoma

Locations shown

Pfizer Investigational Site

San Diego, California

Pfizer Investigational Site

San Kiego, California

Pfizer Investigational Site

North Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 6, 2008Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions